GFAP degradation in TBI: linking novel modified products to astrocyte pathology and patient outcome.
Saved in:
| Title: | GFAP degradation in TBI: linking novel modified products to astrocyte pathology and patient outcome. |
|---|---|
| Authors: | Wanner IB; Semel Institute for Neuroscience and Human Behavior, Intellectual and Developmental Disability Center (IDDRC), Brain Injury Research Center (BIRC), David Geffen School of Medicine, UCLA, 635 Charles E. Young Drive South, NRB315, Los Angeles, CA, 90095, USA. IWanner@mednet.ucla.edu., Halford J; Semel Institute for Neuroscience and Human Behavior, Intellectual and Developmental Disability Center (IDDRC), Brain Injury Research Center (BIRC), David Geffen School of Medicine, UCLA, 635 Charles E. Young Drive South, NRB315, Los Angeles, CA, 90095, USA., Lopez J; Semel Institute for Neuroscience and Human Behavior, Intellectual and Developmental Disability Center (IDDRC), Brain Injury Research Center (BIRC), David Geffen School of Medicine, UCLA, 635 Charles E. Young Drive South, NRB315, Los Angeles, CA, 90095, USA., Shen S; Department of Chemistry and Biochemistry, Molecular Biology Institute, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA., Chen Y; Molecular Instrumentation Center (MIC), Department of Chemistry and Biochemistry, UCLA, Los Angeles, CA, USA., Zhao H; Semel Institute for Neuroscience and Human Behavior, Intellectual and Developmental Disability Center (IDDRC), Brain Injury Research Center (BIRC), David Geffen School of Medicine, UCLA, 635 Charles E. Young Drive South, NRB315, Los Angeles, CA, 90095, USA., Salas C; Semel Institute for Neuroscience and Human Behavior, Intellectual and Developmental Disability Center (IDDRC), Brain Injury Research Center (BIRC), David Geffen School of Medicine, UCLA, 635 Charles E. Young Drive South, NRB315, Los Angeles, CA, 90095, USA., Loo RO; Department of Chemistry and Biochemistry, Molecular Biology Institute, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA., Robicsek S; Department of Anesthesiology, Neurosurgery and Neuroscience, University of Florida, Gainesville, FL, 32610-0254, USA., Ellingson BM; Department of Radiological Sciences, Geffen School of Medicine, UCLA, Los Angeles, CA, USA., Gornbein J; Department of Computational Medicine, Statistics Core of the Department of Medicine, School of Public Health, UCLA, Los Angeles, CA, USA., Van Meter TE; BRAINBox Solutions, Inc., Richmond, VA, 23219, USA., Shaw G; Department of Neuroscience, University of Florida College of Medicine, Gainesville, FL, 32610, USA.; EnCor Biotechnology Inc., Gainesville, FL, 32608, USA., Loo JA; Department of Chemistry and Biochemistry, Molecular Biology Institute, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA., Vespa PM; Department Neurology and Neurosurgery, BIRC, David Geffen School of Medicine, Ronald Reagan Medical Center, UCLA, Los Angeles, CA, USA. |
| Source: | Acta neuropathologica communications [Acta Neuropathol Commun] 2026 Apr 24; Vol. 14 (1). Date of Electronic Publication: 2026 Apr 24. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101610673 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-5960 (Electronic) Linking ISSN: 20515960 NLM ISO Abbreviation: Acta Neuropathol Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42032706 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: GFAP degradation in TBI: linking novel modified products to astrocyte pathology and patient outcome. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wanner+IB%22">Wanner IB</searchLink>; Semel Institute for Neuroscience and Human Behavior, Intellectual and Developmental Disability Center (IDDRC), Brain Injury Research Center (BIRC), David Geffen School of Medicine, UCLA, 635 Charles E. Young Drive South, NRB315, Los Angeles, CA, 90095, USA. IWanner@mednet.ucla.edu.<br /><searchLink fieldCode="AU" term="%22Halford+J%22">Halford J</searchLink>; Semel Institute for Neuroscience and Human Behavior, Intellectual and Developmental Disability Center (IDDRC), Brain Injury Research Center (BIRC), David Geffen School of Medicine, UCLA, 635 Charles E. Young Drive South, NRB315, Los Angeles, CA, 90095, USA.<br /><searchLink fieldCode="AU" term="%22Lopez+J%22">Lopez J</searchLink>; Semel Institute for Neuroscience and Human Behavior, Intellectual and Developmental Disability Center (IDDRC), Brain Injury Research Center (BIRC), David Geffen School of Medicine, UCLA, 635 Charles E. Young Drive South, NRB315, Los Angeles, CA, 90095, USA.<br /><searchLink fieldCode="AU" term="%22Shen+S%22">Shen S</searchLink>; Department of Chemistry and Biochemistry, Molecular Biology Institute, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Chen+Y%22">Chen Y</searchLink>; Molecular Instrumentation Center (MIC), Department of Chemistry and Biochemistry, UCLA, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Zhao+H%22">Zhao H</searchLink>; Semel Institute for Neuroscience and Human Behavior, Intellectual and Developmental Disability Center (IDDRC), Brain Injury Research Center (BIRC), David Geffen School of Medicine, UCLA, 635 Charles E. Young Drive South, NRB315, Los Angeles, CA, 90095, USA.<br /><searchLink fieldCode="AU" term="%22Salas+C%22">Salas C</searchLink>; Semel Institute for Neuroscience and Human Behavior, Intellectual and Developmental Disability Center (IDDRC), Brain Injury Research Center (BIRC), David Geffen School of Medicine, UCLA, 635 Charles E. Young Drive South, NRB315, Los Angeles, CA, 90095, USA.<br /><searchLink fieldCode="AU" term="%22Loo+RO%22">Loo RO</searchLink>; Department of Chemistry and Biochemistry, Molecular Biology Institute, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Robicsek+S%22">Robicsek S</searchLink>; Department of Anesthesiology, Neurosurgery and Neuroscience, University of Florida, Gainesville, FL, 32610-0254, USA.<br /><searchLink fieldCode="AU" term="%22Ellingson+BM%22">Ellingson BM</searchLink>; Department of Radiological Sciences, Geffen School of Medicine, UCLA, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Gornbein+J%22">Gornbein J</searchLink>; Department of Computational Medicine, Statistics Core of the Department of Medicine, School of Public Health, UCLA, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Van+Meter+TE%22">Van Meter TE</searchLink>; BRAINBox Solutions, Inc., Richmond, VA, 23219, USA.<br /><searchLink fieldCode="AU" term="%22Shaw+G%22">Shaw G</searchLink>; Department of Neuroscience, University of Florida College of Medicine, Gainesville, FL, 32610, USA.; EnCor Biotechnology Inc., Gainesville, FL, 32608, USA.<br /><searchLink fieldCode="AU" term="%22Loo+JA%22">Loo JA</searchLink>; Department of Chemistry and Biochemistry, Molecular Biology Institute, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Vespa+PM%22">Vespa PM</searchLink>; Department Neurology and Neurosurgery, BIRC, David Geffen School of Medicine, Ronald Reagan Medical Center, UCLA, Los Angeles, CA, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101610673%22">Acta neuropathologica communications</searchLink> [Acta Neuropathol Commun] 2026 Apr 24; Vol. 14 (1). <i>Date of Electronic Publication: </i>2026 Apr 24. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101610673 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2051-5960 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220515960%22">20515960 </searchLink><i>NLM ISO Abbreviation: </i>Acta Neuropathol Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42032706 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s40478-026-02240-y Languages: – Code: eng Text: English Titles: – TitleFull: GFAP degradation in TBI: linking novel modified products to astrocyte pathology and patient outcome. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wanner IB – PersonEntity: Name: NameFull: Halford J – PersonEntity: Name: NameFull: Lopez J – PersonEntity: Name: NameFull: Shen S – PersonEntity: Name: NameFull: Chen Y – PersonEntity: Name: NameFull: Zhao H – PersonEntity: Name: NameFull: Salas C – PersonEntity: Name: NameFull: Loo RO – PersonEntity: Name: NameFull: Robicsek S – PersonEntity: Name: NameFull: Ellingson BM – PersonEntity: Name: NameFull: Gornbein J – PersonEntity: Name: NameFull: Van Meter TE – PersonEntity: Name: NameFull: Shaw G – PersonEntity: Name: NameFull: Loo JA – PersonEntity: Name: NameFull: Vespa PM IsPartOfRelationships: – BibEntity: Dates: – D: 24 M: 04 Text: 2026 Apr 24 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2051-5960 Numbering: – Type: volume Value: 14 – Type: issue Value: 1 Titles: – TitleFull: Acta neuropathologica communications Type: main |
| ResultId | 1 |